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SUMMARY
Two cases of proven coral snake bites were reported in Belém, Pará State, Brazil. The first case was a severe one caused by 
Micrurus surinamensis. The patient required mechanical ventilation due to acute respiratory failure. The second case showed just 
mild signs of envenomation caused by Micrurus filiformis. Both patients received specific Micrurus antivenom and were discharged 
without further complications. Coral snake bites are scarcely reported in the Amazon region and there is a broad spectrum of clinical 
manifestations, varying from extremely mild to those which may rapidly lead to death if the patient is not treated as soon as possible.
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INTRODUCTION
Coral snakes are the main representatives of the Elapidae in the 
Americas, the genus Micrurus being the most important in terms of 
public health4,6. Due to their large geographical distribution, coral snakes 
may be found in diverse environments6,13. In Brazil, several species of 
Micrurus are found throughout the whole country and a great number of 
them live in the lowland rainforest or tropical jungle6. The Amazon region 
harbors the largest number of species of coral snakes, such as Micrurus 
spixii and M. lemniscatus, and the only species closely associated with 
water environments, the aquatic coral snake, M. surinamensis6,22. These 
species live sympatrically in the Amazon basin31. Coral snakes are largely 
fossorial and seldom seen, even in very dense areas. 
In contrast to viperids, the fangs of coral snakes are short, hollow 
structures that are permanently fixed in position on the anterior maxillary 
bones, which is a feature of proteroglyphous dentition. The short and 
small-sized fangs usually represent low risk to individuals wearing 
footwear and clothing. Most coral snake bites in human beings occur on 
the hands and usually involve a snake that was intentionally picked up 
and handled. This may explain the low number of Micrurus snake bites 
recorded. In 2007, of 22,763 snake bites reported in Brazil, 136 were 
attributed to the genus Micrurus and were without fatalities5. Most cases 
were reported in the Southern region, where M. corallinus is predominant, 
11 occurred in Pará State. 
Studies on Micrurus specific toxins are limited due to the fact that 
these animals are difficult to capture and keep in captivity, and are 
known to produce only a small amount of venom. The genus Micrurus 
possesses a potent neurotoxic venom, which causes postsynaptic 
blockage of neuromuscular transmission by binding competitively to 
the acetylcholine receptors38. The venom of M. corallinus also has a 
neurotoxin with presynaptic activity. These neurotoxins mainly cause 
cranial nerve paralysis in envenomed individuals, leading to so-called 
myasthenic or neurotoxic facies. 
The first sign of peripheral nervous system involvement is usually 
ptosis, often followed by ophthalmoplegia, dysarthria and dysphagia. 
The descendent progression of envenoming may lead to dyspnea. Death 
can be a consequence of muscle paralysis and respiratory arrest. Specific 
antivenom is produced by the immunization of horses with M. corallinus 
and M. frontalis venoms. For other species, including the Micrurus 
species of the Amazon region, studies on their mechanisms of action 
and the neutralizing effects of antivenoms are rarely available2. Clinical 
descriptions of patients bitten by Micrurus are still much needed and 
therefore we describe two cases in which the severity of envenomation 
varied considerably. 
CASE REPORTS
Case 1: An 18 year-old male, Biology student, was reportedly 
walking on a university campus belonging to the University of Rural 
Amazon, Belém, Pará State, when he found an 80-cm coral snake (Fig. 
1). In an attempt to capture the animal, he was bitten on the left thumb. 
Immediately, the patient pulled the snake off so the animal did not hold 
on to the site of the bite. Only one fang mark was visible. He did not 
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complain of having any pain but he mentioned paresthesia at the bite site 
that went up along the whole limb a few minutes after the accident. He 
had been sent to the reference hospital, João de Barros Barreto University 
Hospital, where he arrived within 20 minutes after the bite took place, 
bringing with him a M. surinamensis coral snake. Upon arrival, he 
complained of blurred vision and difficulty in speaking, walking and 
opening his eyelids. On examination, he was in respiratory distress (40 
mpm), foaming at the nose and mouth, conscious but unable to speak. 
He was not cyanosed or in shock. The pulse rate and blood pressure were 
normal (100/80 mmHg). He was intubated and transferred to the Intensive 
Care Unit (ICU) where he was immediately put on a ventilator, followed 
by IV administration of neostigmine methylsulfate (0.5mL = 5 mg), 
preceded by atropine sulfate (1mL = 0.25 mg), and 100 mL of Micrurus 
antivenom, produced by the Butantan Institute (São Paulo) in ampoules 
of 10 mL containing: F(ab’)2 horse antibodies, 1 mL neutralizing at least 
10 mg of M. frontalis reference-venom in mice. In the ICU the patient 
was found to be unconscious. The chest was clear and heart sounds were 
normal. Initial laboratory studies were normal (Table 1). Approximately 
12 hrs after the development of neurological symptoms, the patient was 
alert and following commands with a normal physical examination. 
Neostigmine administration did not apparently reverse any neurological 
manifestation. The patient could be weaned from artificial ventilation 48 
hours after antivenom infusion. No further medication was required and 
the patient was discharged in a good condition on day 3.
Case 2: A 19 year-old male was handling a colored snake which 
Fig. 1 - Micrurus surinamensis, specimen responsible for severe envenoming (Case 1). 
Table 1 






(24hrs after AV therapy)
13/April/2006 
(without artificial ventilation)
Arterial blood gas analysis
pH 7.36 7.51 7.41
pCO
2
 (mmHg) 32 26 40
pO
2
 (mmHg) 379 198 283
HCO
3
 (mEq/L) 18 21 25
Total CO
2
 (mmol/L) 19 -- 26
BE (mmol/L) - 6 + 1
Std. BE - 6 - 1 + 1
Std. BC 20 -- 25
Sat. O
2
 (%) 100 100 100
FiO
2 
(%) 40 50 50
Hemoglobin (g/dL) 13.2 -- --
Total leukocytes (count/mm3) 18,500 -- --
Platelets (count/mm3) 230,000 -- --
*Patient was already on artificial ventilation.
Fig. 2 - Micrurus filiformis, specimen responsible for mild envenoming (Case 2).
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had been captured the day before in the village of Boa Vista in the Acará 
municipality, Pará State. He reported that he had been bitten on a left-
hand finger and complained of mild pain. He stated that approximately 
one hour after the accident he noticed a mild swelling on the bitten 
limb and complained of epigastric pain. He mentioned two episodes of 
vomiting. Upon physical examination everything seemed normal apart 
from a small puncture wound on the fourth finger of the left hand with 
very mild edema. He had no blurred vision, ptosis or other symptom of 
neurotoxicity. He was given 100 mL of Micrurus antivenom and fully 
recovered while in the hospital. He was discharged 24 hours after the 
antivenom therapy with only mild edema on the hand, and remained 
asymptomatic. The snake was identified as a 50-cm specimen of Micrurus 
filiformis (Fig. 2) by the Herpetology Laboratory of the Emílio Goeldi 
Museum, Belém, Pará State.
DISCUSSION
Two cases of human Micrurus envenoming are here presented, 
one caused by M. surinamensis and the other by M. filiformis, which 
show the potential for severe envenoming and the variability of the 
clinical manifestations. In Brazil, Micrurus envenoming is relatively 
rare and most cases are due to M. corallinus, M. lemniscatus and M. 
frontalis6,9,20,32,39. 
Although broadly distributed across the whole country, the number 
of Micrurus accidents is negligible, when compared to cases involving 
Bothrops and Crotalus snakes4. The rarity of human accidents is attributed 
to the type of dentition and envenoming which would result from a bite 
on a small part of the body, such as fingers, which enables the snake to 
hold on and to inoculate its venom into tissues by means of a chewing 
motion25. Contrary to this common view, Case 1 illustrates the capability 
of the coral snake in delivering a potentially severe bite without having 
to “chew” on the victim for a long period of time. Thus, envenoming 
should be diagnosed by the presence of the signs and symptoms of 
neurotoxicity. Fang marks may or may not be evident and when they are 
present, they are usually slight and may be seen as scratch marks. Even 
the absence of visible fang marks does not preclude the possibility of a 
bite with venom inoculation25.
Micrurus venoms are known to possess neurotoxic properties37. In 
most symptomatic cases neuromuscular paralysis is the most prominent 
and is caused by postsynaptic motor end-plate blockage of acetylcholine 
receptors, which produces similar effects to those seen in myasthenia 
gravis18 and curare poisoning24. This prevents nerves from stimulating 
muscle contraction and leads to paralysis. Similar actions are described 
for other Elapidae venoms, such as Naja and Bungarus spp14,19.
The two cases reported here presented different clinical aspects. The 
first progressed rapidly to respiratory distress while the other showed 
only mild edema without any neurological manifestations up to 24 
hrs after bite. This broad spectrum of clinical manifestations in snake 
bites is generally known to occur. Cases of patients bitten by elapid 
snakes that did not receive antivenom and did not present neurological 
manifestations have been reported and characterized as asymptomatic or 
dry-bites6. It is important to point out that there are few studies available 
to understand the exact mechanism of action of Micrurus venoms, and 
some variation in their composition may be present among different 
species. Most experimental studies involve M. frontalis and M. corallinus 
venoms, since these two species are the most frequent cause of Micrurus 
envenoming in Brazil33. M. surinamensis venom is known to contain 
postsynaptic toxins33. One experimental study with Micrurus venoms 
from the Amazon, including M. spixii, M. averyi, M. lemniscatus and M. 
surinamensis, showed no coagulant activity but edematogenic effects, 
except for M. surinamensis2. Another study evaluated the biological 
and enzymatic activities of M. surinamensis venom but not those of M. 
filiformis8.
Antivenom administration is recommended as the most efficacious 
treatment for envenoming by coral snakes6,17. Specific Micrurus 
antivenoms, produced in Brazil by the Butantan Institute (São Paulo) and 
the Ezequiel Dias Foundation (Minas Gerais), are produced in horses 
immunized with the venoms of M. corallinus and M. frontalis29. However, 
some studies suggest that the neutralizing capacity of antivenoms may 
be improved by including venom from other Micrurus species in the 
venom pool used in the immunization protocol1,10,15,36. 
The assumption that commercial antivenoms may be used in the 
treatment of bites by any Brazilian Micrurus species, even for other 
South American coral snakes contrasts with the scarcity of clinical 
studies on envenoming by Micrurus coral snakes, which are limited 
to case reports3,6,21,27,40. Unusual symptoms of envenoming by M. 
lemniscatus have been described21 in which the patient had severe pain 
in the bitten limb, despite repeated doses of potent analgesics, and no 
response to anti-cholinesterase or specific antivenoms was observed, 
either. In contrast, our patients had no intense local pain, but the Case 2 
patient presented mild local swelling and pain, which is in accordance to 
experimental reports that have shown that some Micrurus venoms may 
induce myotoxicity and local lesions2. 
Reports on Elapidae snake bites in Australia have suggested that 
pressure immobilization bandaging of the affected limb could impede 
the egress of toxins from the site of the bite and delay the onset of life-
threatening systemic involvement23,35. On the other hand, experimental 
studies have suggested that attaining the recommended pressure levels 
is technically very difficult and the effective use of this method might 
require extensive training and experience26. Because of this and time 
wastage concerns, in Brazil emphasis is given to improving antivenom 
supply and distribution, and instructions are that all victims should be 
transported to the nearest medical treatment facility as soon as possible. 
Neurologic signs and symptoms of envenoming can be apparent 
in minutes, or be delayed for as long as 12 hours. In Case 1, the rapid 
onset of clinical manifestations indicates the severity of envenoming 
and the necessity of prompt intervention, not only with antivenom, 
but also with intensive care supportive measures. Moreover, improved 
methods of reversing the effects of neurotoxicity are needed. Even when 
administered early, antivenoms did not promptly reverse paralysis. 
Improvement in neurological signs was not seen until 24 hours after 
antivenom administration. Ancillary treatment has been recommended 
with anti-cholinesterase drugs; Edrophonium Chloride could benefit those 
patients bitten by a coral snake with postsynaptic neurotoxic venom41, and 
neostigmine had demonstrated the potential to reverse neuroparalysis9,39. 
Even when used in several occasions in clinical practice, no standard 
protocol has been followed. Our patient, for instance, had received a half 
dose of that used in other studies5. The failure of neostigmine in reversing 
neurotoxicity in Case 1 may be partially attributed to an insufficient dose. 
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On the other hand, the very mild symptoms observed in Case 2 
suggest that coral snake bites are not necessarily always severe. There 
is no generally accepted clinical classification for severity of accidents, 
and an empirical dose of 10 ampoules of antivenom is usually given, 
regardless of severity. A review of the classification of severity is thus 
needed to adjust the amount of antivenom to the real necessity in case 
of mild, moderate or severe envenoming, as exists for Bothrops and 
Crotalus envenoming.
Coral snakes are widely distributed in almost all major ecological 
regions of the New World, and a great number live in the lowland rain 
forest, particularly in the Amazon region of Brazil22. This area harbors 
the largest number of species of coral snakes, such as Micrurus spixii 
and M. lemniscatus, as well as the only species closely associated with 
water environments, the aquatic coral snake, M. surinamensis30. From all 
the Micrurus spp. that are found in Brazilian Amazon, M. surinamensis 
is one of the largest in girth and length, reaching up to 1,350 mm6. It 
inhabits humid tropical forests and secondary forests, near water flows 
of the Amazonas and Orinoco Rivers, in the Northern and Central parts 
of South America11,12,14,30. A proteomic analysis of the venom of the fish-
eating M. surinamensis provides an overview of its protein composition, 
the specific pharmacological features of which differ from other Micrurus 
species28. Micrurus filiformis is also broadly distributed in the Amazon 
basin and may be found in secondary forests, low altitude mountains, 
open fields, and humid forests7,16,30. 
In general, coral snakes are not abundant in nature, thus the scarcity 
of specimens is one reason why they are not well known, and their elusive 
habits are a key for their success in at least partially avoiding decimation 
by humans. But, as colorful and distinctive snakes, they sometimes appeal 
to humans to be handled and observed. With the increasing spread of the 
habit of keeping snakes as pets, it is important to identify elapids and 
distinguish them from false coral snakes, and also to spread information 
about first aid and treatment.
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RESUMO
Envenenamento por coral do gênero Micrurus na Amazônia 
brasileira: relato de dois casos
Dois acidentes por coral verdadeira são descritos em Belém, 
Pará. O primeiro caso foi decorrente de envenenamento por Micrurus 
surinamensis, no qual a vítima necessitou ventilação mecânica por 
insuficiência respiratória. O segundo, causado por Micrurus filiformis, 
apresentou apenas manifestações leves. Ambos os pacientes receberam 
soro antielapídico específico e evoluíram sem complicações. Acidentes 
por coral verdadeira na região Amazônica são raramente descritos e 
podem cursar com um largo espectro de alterações, que variam desde 
quadros de envenenamento muito leves até manifestações com risco de 
óbito.
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